(LFST) – Press Releases
-
LifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024
-
CannMart Marks International Debut with First Shipment of Cannabis Products to Australia
-
Lifeist Initiates Restructuring Proceedings for CannMart Labs Inc.
-
Lifeist Reports Fourth Quarter 2023 Financial Results
-
Lifeist's CannMart to Offer Roilty Products in Quebec
-
Lifeist Announces Results of Annual General and Special Meeting of Shareholders
-
Aussie Vapes Enjoys Single Highest Day of Sales in Its History
-
LifeStance Appoints Dr. Teresa DeLuca to Board of Directors
-
Corporate Update: Meni Morim to Step Down as CEO
-
Aussie Vapes Granted Import License in Australia
-
LifeStance Reports Fourth Quarter and Full Year 2023 Results
-
CannMart Reports Growth in Key Markets of Alberta and Ontario with In-house Brand Roilty Ranking as the Second Best-Selling Concentrate in 2023
-
Mikra PROTECT Immune Support Gummy Now Shipping
-
Mikra Reports Further Clinical Research that Validates Category-Defining Formulation of CELLF Cellular Health Supplement
-
CannMart to Expand Roilty Product Portfolio to Include Craft and Solventless Offerings
-
LifeStance to Host Fourth Quarter and Full Year 2023 Earnings Conference Call on February 28, 2024
-
Lifeist Announces Sale of CannMart
-
LifeStance Appoints Dr. Ujjwal Ramtekkar as Chief Medical Officer
-
Mikra Launches New Immune Protect Gummies with Bundle Sales Promotion
-
CannMart to Process First International Export of Medical-Use Cannabis to Australia
-
Mikra to Introduce Innovative Immune Support Gummy
-
CannMart Brand Roilty Secures Coveted KIND Award for Best Marketing Campaign of the Year
-
Clinical Research Shows the Active Ingredient in Mikra’s Serenity Matches a Benzodiazepine in Effectiveness at Fighting Anxiety, Without Being Habit-Forming
-
Mikra Successfully Launches Serenity, an Innovative Mental Health Product for Anxiety
-
Mikra Receives First Shipment of Serenity, an Innovative Mental Health Product for Anxiety, in Time for Black Friday
-
Mikra Introduces Serenity, an Innovative Mental Health Product for Anxiety, Available for Purchase on Black Friday
-
CannMart Launches Roilty in Newfoundland & Labrador, Receives Multiple AdCann Award Nominations and Named Title Sponsor at the 2024 CannExpo
-
LifeStance Reports Third Quarter 2023 Results
-
Lifeist's Mikra Completes Formulation of Innovative Mental Health Product for Anxiety
-
Lifeist Reports Third Quarter 2023 Financial Results
-
Lifeist Terminates Agreement for Sale of Australian Vapes
-
LifeStance to Host Third Quarter 2023 Earnings Conference Call on November 8, 2023
-
Lifeist’s CannMart Expands Product Listings to the Province of Newfoundland and Labrador and Supports Growth Trajectory Through Marketing Activities
-
Lifeist's Mikra Introduces Innovative New Mental Health Product and Provides Corporate Update
-
LifeStance to Present at the 7th Annual Bernstein Healthcare Services Disruptors Conference
-
Lifeist Announces Sale of Non-core Subsidiary Australian Vapes
-
Lifeist Strengthens Board with New Appointment and Announces Changes to Chief Financial Officer and Auditor
-
LifeStance to Present at the 21st Annual Morgan Stanley Healthcare Conference
-
Lifeist's CannMart Maintains Momentum with Cannabis Category Growth
-
LifeStance Reports Second Quarter 2023 Results
-
Lifeist's CannMart Increases Zest Cannabis Sales and Provides Corporate Update
-
Lifeist Reports Second Quarter 2023 Financial Results
-
Lifeist Wellness Closes on Zest Acquisition
-
LifeStance to Host Second Quarter 2023 Earnings Conference Call on August 9, 2023
-
Lifeist's CannMart Successfully Launches Multi-Pack Concentrates in British Columbia
-
Lifeist Wellness to Acquire Fast-Growing ‘Zest’ Brand
-
LifeStance to Present at the 44th Annual Goldman Sachs Healthcare Conference
-
Lifeist’s CannMart Reports Growth Across Popular Categories and New Product Launches
-
Gennev and LifeStance Health Partner to Provide Integrated Care for Women in Menopause
-
LifeStance Reports First Quarter 2023 Results
Back to LFST Stock Lookup
